TY - JOUR
T1 - Optimizing Patient Selection for Bevacizumab Plus Irinotecan in Recurrent High Grade Glioma: Superiority of the Neutrophil-to-Lymphocyte Ratio Over Other Systemic Inflammation Indices
Y1 - 2026
PY - 2026
DA - 2026
N1 - doi:263037
T2 - EURASIAN JOURNAL OF MEDICIAL INVESTIGATION
JF - EURASIAN JOURNAL OF MEDICIAL INVESTIGATION
JO - EJMI
SP - 37
EP - 45
VL - 10
IS - 1
SN - 
M3 - doi:263037
UR - https://dx.doi.org/10.14744/ejmi.263037
Y2 - 2026
ER -